预防性去氧肾上腺素输注对剖宫产腰麻布比卡因ED50和ED95的影响
结果显示去氧肾上腺素组ED50为10.0 mg、ED95为14.1 mg,均高于对照组的7.9 mg和11.7 mg,提示预防性输注去氧肾上腺素会增加腰麻布比卡因的剂量需求。
要点
- 预防性去氧肾上腺素输注组腰麻布比卡因ED50为10.0 mg,对照组为7.9 mg。
- 去氧肾上腺素组ED95为14.1 mg,对照组为11.7 mg。
- 预防性去氧肾上腺素输注时需考虑增加腰麻布比卡因剂量。
核心结论
- 预防性去氧肾上腺素输注导致剖宫产产妇腰麻重比重布比卡因的剂量需求增高。
研究设计与样本
- 产妇随机接受预防性去氧肾上腺素或生理盐水(对照)输注,并接受6、7.5、9、10.5或12 mg腰麻重比重布比卡因。
- 有效剂量定义为腰麻注药后10分钟内达到T5感觉平面且无需硬膜外补充。
主要发现
- 预防性去氧肾上腺素组腰麻重比重布比卡因ED50为10.0 mg(95%CI 5.9-11.4 mg),对照组为7.9 mg(95%CI 2.3-9.4 mg)。
- 预防性去氧肾上腺素组ED95为14.1 mg(95%CI 12.3-37.6 mg),对照组为11.7 mg(95%CI 9.9-22.8 mg)。
临床怎么用
- 剖宫产腰麻时若使用预防性去氧肾上腺素输注,应考虑到腰麻布比卡因需要更高剂量才能达到相同阻滞平面。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: While prophylactic phenylephrine infusions during cesarean delivery are often used to counteract the sympathectomy associated with spinal anesthesia, their use has been associated with decreased rostral spread of local anesthetic. The purpose of this study was to determine the median effective dose (ED50) and 95% effective dose (ED95) of intrathecal hyperbaric bupivacaine for cesarean delivery in the presence and absence of prophylactic phenylephrine infusion. METHODS: One hundred healthy parturients undergoing elective cesarean delivery under combined spinal-epidural anesthesia were enrolled in this randomized, double-blind, dose-finding study to determine ED50 and ED95. Subjects were randomly assigned to receive prophylactic phenylephrine or control (saline) infusion with injection of 6, 7.5, 9, 10.5, or 12 mg intrathecal hyperbaric bupivacaine. An effective dose was defined as achieving a T5 sensory level within 10 minutes of intrathecal drug administration without the need for epidural supplementation. RESULTS: The ED50 of intrathecal hyperbaric bupivacaine was 10.0 mg (95% confidence interval [CI], 5.9-11.4 mg) with prophylactic phenylephrine infusion and 7.9 mg (95% CI, 2.3-9.4 mg) in the control group. The ED95 of intrathecal hyperbaric bupivacaine was 14.1 mg (95% CI, 12.3-37.6 mg) with prophylactic phenylephrine infusion and 11.7 mg (95% CI, 9.9-22.8 mg) in the control group. CONCLUSIONS: The administration of prophylactic phenylephrine infusion results in higher intrathecal hyperbaric bupivacaine dosing requirements in parturients undergoing cesarean delivery. CLINICAL TRIAL REGISTRATION: This study was registered at the Chinese Clinical Trial Registry, identifier ChiCTR-TRC-16008938.
引用
- Xiao F, Drzymalski D, Liu L, et al. Comparison of the ED50 and ED95 of Intrathecal Bupivacaine in Parturients Undergoing Cesarean Delivery With or Without Prophylactic Phenylephrine Infusion: A Prospective, Double-Blind Study. Reg Anesth Pain Med. 2018. PMID: 30063658. doi:10.1097/AAP.0000000000000850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。